Trial intelligence / Profile preview

Preoperative vs Intraoperative Carbon Nanoparticles in Thyroid Cancer Surgery

NCT06791005Phase 3Recruiting

Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Start
Jan 2025
Primary completion
Jun 2025
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 3 trial of carbon nanoparticles in papillary thyroid cancer (PTC), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Started Jan 2025; status: recruiting.

02

Drugs

carbon nanoparticles
03

Conditions

papillary thyroid cancer (PTC)

Beyond the preview

Go deeper on NCT06791005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06791005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call